OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Editorial Board	100
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”	86
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio	86
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles	83
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study	76
Editorial Board	76
Editorial Board	75
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study	70
Homogeneity and mechanical properties of orodispersible films loaded with pellets	69
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery	62
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps	61
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody	60
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]	59
COSMO models for the pharmaceutical development of parenteral drug formulations	58
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans	52
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes	52
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration	51
Question-based review for pharmaceutical development: An enhanced quality approach	50
Topical liquid formulation of bacteriophages for metered-dose spray delivery	47
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids	45
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine	44
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations	44
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response	41
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment	41
Rationalisation of the purification process for a phage active pharmaceutical ingredient	40

Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells	39
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions	39
In silico evaluation of corneal patch eluting anti-VEGF agents concept	38
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development	37
Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction	36
Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study	35
Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway	35
Formulation strategies to provide oxygen-release to contrast local hypoxia for transplanted islets	34
Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet	33
Obtaining two polymorphic forms of paracetamol within the phase diagram with PEG 1500	33
Photo-induced site-specific oxidative fragmentation of IgG1 mediated by iron(III)-containing histidine buffer: Mechanistic studies and excipient effects	33